JOHN DAVID HANSEN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN DAVID HANSEN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN DAVID HANSEN. JOHN DAVID HANSEN is a V.P. of Corporate Development in AVANIR PHARMACEUTICALS, INC. ($AVNR) and a President and CEO in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).

Address: 11388 SORRENTO VALLEY ROAD, SUTIE 200 SAN DIEGO 92121 CA

Companies in which JOHN DAVID HANSEN is an Insider

AVANIR PHARMACEUTICALS, INC.

Trading Symbol: AVNR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN DAVID HANSEN: V.P. of Corporate Development
Holdings: 15,000 shares
Latest Transaction: Jan 03 2005

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

MABVAX THERAPEUTICS HOLDINGS, INC.

Trading Symbol: MBVX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN DAVID HANSEN: President and CEO
Holdings: 536,730 shares
Current Value: $1,594,088
Latest Transaction: Feb 23 2018
$MBVX Market Capitalization: $18.01M
$MBVX Previous Close: $2.97

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 12x
Shares Bought: 1,081,228
Shares Sold: 381,844
Share Difference: +699,384
Value Difference: +$267,642

Latest Insider Trading Transactions of JOHN DAVID HANSEN

Sentiment: All, AVNR, MBVX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 23 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseA2.04290,000591,600290,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseA2.04290,000591,600290,000
Jan 18 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS0.9259,26354,522536,730596 K to 536.7 K (-9.94 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseM0.00727,21000
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS0.9618,58217,839595,993614.6 K to 596 K (-3.02 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS0.9864,01562,735614,575678.6 K to 614.6 K (-9.43 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS0.96110,093105,689678,590788.7 K to 678.6 K (-13.96 %)

View all JOHN DAVID HANSEN insider transactions.